SANTA ROSA, Calif., Sept. 1, 2011 /PRNewswire/ — Today,
Osseon® Therapeutics, Inc. launched the Osseoflex®SN
(steerable needle). Osseoflex SN is the newest in Osseon’s suite of
minimally invasive products for treatment of spinal compression
fractures.
(Photo: http://photos.prnewswire.com/prnh/20110901/SF61461)
The Osseoflex SN allows direct unipedicular access to the entire
vertebral body. The Osseoplasty™ procedure offers
unparalleled flexibility and control for percutaneous vertebral
augmentation, cement delivery, and fracture stabilization,
resulting in significant pain relief for most patients within the
same day.
“Osseoflex SN is the next generation of steerable, minimally
invasive cement delivery devices for the treatment of osteoporosis
and related bone diseases and injuries. Our technology for
vertebral compression fracture treatment offers increased
precision, less operating time for physicians and decreased risk
for patients,” said John Stalcup, Ph.D., Osseon’s CEO and
President.
Osseon Therapeutics currently markets Osseoflex®SN
(steerable needle), Osseoperm® (bone cement), Osseoflex®DR
(steerable bone drill), Osseoflex®BT (steerable bone tamp), and
Osseoflex®Access (bone access kit). Together, Osseon’s suite of
products provides groundbreaking biomedical devices for physicians
who treat vertebral compression fractures due to osteoporosis,
myeloma, and acute osteo-traumatic injuries.
About Osseon
Osseon Therapeutics, Inc. focuses on bringing to market
alternative minimally invasive treatments for degenerative
bone and joint disease. Headquartered in Santa Rosa, CA, the
company’s groundbreaking technology and delivery systems provide
efficacy and safety competitive with all other commercial
solutions, while delivering superior efficiency and
cost. By improving the tre
‘/>”/>
SOURCE
